Stock Ticker

  • Loading stock data...

Johnson & Johnson (NYSE:JNJ) Promises Enough COVID-19 Vaccine Doses For Americans By Spring

Johnson & Johnson (NYSE:JNJ) is expecting that by April it will have adequate COVID-19 vaccine doses for over 100 million Americans as nationwide vaccination efforts ramp up. JNJ to ramp up vaccine production Dr. Mark McClellan, the company’s board member, and former FDA administrator indicated that JNJ will go all out in the production of […]

Virus Plays in Focus as 2021 Gets in Gear (NVAX, HALB, MRNA)

The re-opening narrative is dominating activity in the market and governs decisions being made in the business economy, and with good reason. Perhaps never before has so much value been tied to such a singular and distinct dynamic. That naturally defines the value proposition of companies working to provide those solutions. With vaccines a powerful […]

Moderna, Inc. (NASDAQ: $MRNA), Q BioMed Inc (OTC: $QBIO) and Gilead Sciences (NASDAQ: $GILD) are getting a lot of attention now

Biotech stocks have continued to be market-leading targets for investors through the coronavirus stock market crash and rebound. Moderna, Inc. (NASDAQ: $MRNA), Q BioMed Inc (OTC: $QBIO) and Gilead Sciences (NASDAQ: $GILD) are getting a lot of attention now. Having been the first group to start testing a vaccine against SARS-CoV-2, Moderna inc (NASDAQ: MRNA) […]